GenSci145
/ GeneScience
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 13, 2026
GenSci145 as Monotherapy or in Combination Therapy, in Participants With PIK3CA-mutated, Locally Advanced or Metastatic Solid Tumors.
(clinicaltrials.gov)
- P1 | N=186 | Not yet recruiting | Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Monotherapy • New P1 trial • Breast Cancer • Colorectal Cancer • Solid Tumor • ER • HER-2 • PGR • PIK3CA
1 to 1
Of
1
Go to page
1